Busulfan, Cyclophosphamide, Antithymocyte Globulin [clinicaltrials_resource:4168f3f0d3ef799b7707becf6c9a0fa5]
intervention [clinicaltrials_vocabulary:intervention]
Busulfan, Cyclophosphamide, Antithymocyte Globulin [clinicaltrials_resource:4168f3f0d3ef799b7707becf6c9a0fa5]
Bio2RDF identifier
4168f3f0d3ef799b7707becf6c9a0fa5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4168f3f0d3ef799b7707becf6c9a0fa5
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Subjects will receive BUSULFAN ...... a pre-medication for the ATG.
intervention name [clinicaltrials_vocabulary:intervention-name]
Busulfan, Cyclophosphamide, Antithymocyte Globulin
other name [clinicaltrials_vocabulary:other-name]
Busulfex, Cytoxan, ATG
identifier
clinicaltrials_resource:4168f3f0d3ef799b7707becf6c9a0fa5
title
Busulfan, Cyclophosphamide, Antithymocyte Globulin
@en
type
label
Busulfan, Cyclophosphamide, An ...... 8f3f0d3ef799b7707becf6c9a0fa5]
@en